NCT03311256 is a clinical trial of Tissue Transit Time in Renal Insufficiency, Acute, sponsored by University Hospital Tuebingen.

Who is sponsoring NCT03311256?

NCT03311256 is sponsored by University Hospital Tuebingen.

What drugs are being tested in NCT03311256?

Interventions in NCT03311256: Tissue Transit Time.

What condition does NCT03311256 study?

NCT03311256 studies Renal Insufficiency, Acute.

Is NCT03311256 still recruiting?

NCT03311256 is currently completed. Last updated 9 May 2022.

Last reviewed 2022-05-09 · How we verify

NCT03311256

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Determination of the "Tissue Transit Time" (TTT)

Completed Last updated 9 May 2022

What this trial tests

trial testing Tissue Transit Time in Renal Insufficiency, Acute in 119 participants. Completed in 24 November 2021.

Timeline

23 November 2017

Primary endpoint
30 June 2021

24 November 2021

Quick facts

Lead sponsor	University Hospital Tuebingen
Status	Completed
Study type	OBSERVATIONAL
Enrollment	119
Start date	23 November 2017
Primary completion	30 June 2021
Estimated completion	24 November 2021
Sites	9 locations across Switzerland, Germany

Drugs / interventions tested

Tissue Transit Time

Conditions studied

Renal Insufficiency, Acute — all drugs for Renal Insufficiency, Acute →

Sponsor

University Hospital Tuebingen

Who can join

Under 3 Months, any sex, with Renal Insufficiency, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Determination of Tissue Transit Time (TTT) as a parameter with high prognostic value to predict the functional course of the differential renal function and the development of the differential renal function after pyeloplasty

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Renal Insufficiency, Acute

Currently open trials in the same condition.

NCT04334707 — Kidney Precision Medicine Project · recruiting

Other University Hospital Tuebingen trials

Trials by the same sponsor.

NCT07378670 — DEfeating PEnile CAncer-2 · NA · recruiting
NCT07276503 — Verification of a New Predictive Delirium Score in Adults With Elective Cardiac Valve or Bypass Surgery With Perioperati · not yet recruiting
NCT07411365 — Dual-task Cognitive-motor Telerehabilitation in Persons With PD-MCI · NA · not yet recruiting
NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
NCT07378891 — Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI) · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03311256 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Tuebingen
Last refreshed: 9 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03311256.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing